The US nicotinamide prices saw a significant increase in February, influenced by rising freight costs and geopolitical unrest. Tensions in the Middle East have impacted crude oil and energy prices, further straining supply chains. Early in the month, escalating freight rates along the Shanghai–Houston corridor, coupled with shifts in Chinese export allocations towards higher-margin markets, limited the availability of nicotinamide in the US. Proactive restocking by contract manufacturers ahead of spring marketing efforts helped maintain stable call-off volumes despite tightening conditions. Demand for nicotinamide remained strong in dietary supplements and functional beverages, driven by a growing interest in health and wellness. Looking ahead, analysts expect continued price pressure into March, influenced by increased feedstock costs and high freight charges. While seasonal restocking will likely support buying momentum, the outlook remains contingent upon fluctuations in feedstock availability and any further escalation in geopolitical tensions that could disrupt logistics. Stakeholders must stay vigilant to navigate this dynamic market landscape.
